An explainer on the FDA approval of Lilly's Zepbound and what it changes for patients and providers. Older news with no new details given.
Recap by typeshit. Full story at ΕΜΥ.
The $49 virtual weight management visits now cover insurance checks and Medicare GLP-1 Bridge support, with pharmacists contacting everyone who starts a fill.
A press release announces Woodward's new book, which she says debunks common peptide myths aimed at women. No other details were given.
A local feature on clinics in Sarasota using peptides for recovery, hormones and wellness. The claims come from the practitioners and are not backed by cited evidence.
Endpoints News
The Copenhagen drugmaker has a slate of weight loss candidates but says its future depends on building a much wider pipeline.
A Harvard and Copenhagen review found 43 percent of users eat too little protein, and a Northwestern study saw deficiencies in nearly one in six teens.
The health committee says the plan to reach 220,000 people would cover only 6% of 2.8 million eligible patients, and suggests using digital providers.
Loading…